ZNTL Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $2.52

Piyasa Değeri (MRQ) $181M

P/E -1.4

Hisse Başına Kâr $-1.91

Gelir $0

ROE -49.5%

52 Haftlık Aralık $1–$7

ZNTL Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$0

2022-12-31 → 2025-12-31

Hisse Başına Kâr$-1.91

2019-12-31 → 2025-12-31

Serbest Nakit Akışı$-125M

2020-12-31 → 2025-12-31

Net kar marjı·

2024-12-31 → 2024-12-31

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	ZNTL	5Y ort.	Akran Ortalaması	Sonuç
P/E	-1.45Y ort. ≈-6.5	≈-6.5	·	·
F/D (MRQ)	1.35Y ort. ≈1.6	≈1.6	2.5	Adil değer
Fiyat / Serbest Nakit Akışı (TTM)	-1.45Y ort. ≈-3.6	≈-3.6	·	·
Fiyat / Nakit Akışı (TTM)	-1.45Y ort. ≈-3.6	≈-3.6	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	0.85Y ort. ≈3.4	≈3.4	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	ZNTL	5Y ort.	Akran Ortalaması	Sonuç
ROA	-38.1%5Y ort. ≈-43.3%	≈-43.3%	-49.3%	En üst düzey
ROE	-49.5%5Y ort. ≈-54.7%	≈-54.7%	-49.5%	Aynı seviyede
ROIC	-70.9%5Y ort. ≈-62.1%	≈-62.1%	-129.3%	En üst düzey

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	ZNTL	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		4.85Y ort. ≈7.3	≈7.3	5.1	Aynı seviyede
Quick Ratio (Cari Oran)		1.05Y ort. ≈0.7	≈0.7	2.7	Düşük likidite

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	ZNTL	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-1.915Y ort. ≈$-3.38	≈$-3.38	·	·
Revenue / Share (Hisse Başına Gelir)	$0.00	·	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-1.745Y ort. ≈$-2.61	≈$-2.61	·	·
Cash / Share (Hisse Başına Nakit)	$0.525Y ort. ≈$0.53	≈$0.53	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	ZNTL	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)	0.0	·	0.1	Zayıf
Receivables Turnover (Alacak Devir Hızı)	0.0	·	6.2	Zayıf
Revenue / Employee (Çalışan Başına Gelir)	≈$0.00	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 13.0%

Sonraki Rapor Kas 09, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Ağu 4, 2026	$-0.59	$-0.50	-18.1%
31 Mart 2026	May 12, 2026	$-0.50	$-0.49	-2.9%
31 Aralık 2025		$-0.50	$-0.59	15.3%
30 Eylül 2025		$-0.37	$-0.54	31.3%
30 Haziran 2025		$-0.37	$-0.59	37.6%
31 Mart 2025		$-0.56	$-0.65	13.9%
31 Aralık 2024		$-0.62	$-0.72	13.9%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 13

Metrik	2025	2024	2023	2022
Revenue	$0	$67M	$0	$0
R&D Expense	$107M	$168M	$190M	$173M
SG&A Expense	$38M	$87M	$64M	$55M
Operating Expenses	$153M	$259M	$300M	$227M
Operating Income	$-153M	$-191M	$-300M	$-227M
Pretax Income	$-137M	$-166M	$-293M	$-238M
Income Tax	$442.0K	$177.0K	$-601.0K	$-469.0K
Net Income	$-137M	$-166M	$-292M	$-237M
EPS (Basic)	$-1.91	$-2.33	$-4.47	$-4.48
EPS (Diluted)	$-1.91	$-2.33	$-4.47	$-4.48
Shares (Basic)	71,869,000	71,080,000	65,409,000	52,857,000
Shares (Diluted)	71,869,000	71,080,000	65,409,000	52,857,000
EBITDA	$-152M	$-190M	$-298M	$-226M

Bilanço 23

Metrik	2025	2024	2023	2022
Cash & Equivalents	$36M	$34M	$28M	$43M
Receivables	$0	$5M	$0	·
Prepaid Expense	$7M	$10M	$14M	$15M
Current Assets	$253M	$386M	$497M	$452M
PP&E (Net)	$3M	$5M	$6M	$8M
PP&E (Gross)	$6M	$9M	$9M	$10M
Accum. Depreciation	$3M	$4M	$3M	$2M
Goodwill	·	$0	$4M	$4M
Total Assets	$289M	$430M	$552M	$539M
Accounts Payable	$7M	$7M	$15M	$11M
Accrued Liabilities	$29M	$45M	$54M	$45M
Current Liabilities	$37M	$53M	$69M	$57M
Capital Leases	$36M	$40M	$43M	$45M
Deferred Tax	·	·	$0	$853.0K
Other Non-current Liabilities	$500.0K	$849.0K	$2M	$3M
Total Liabilities	$73M	$93M	$114M	$105M
Common Stock	$69.0K	$71.0K	$70.0K	$59.0K
Paid-in Capital	$1.41B	$1.39B	$1.32B	$1.03B
Retained Earnings	$-1.19B	$-1.05B	$-889M	$-596M
AOCI	$196.0K	$558.0K	$2M	$-1M
Stockholders' Equity	$216M	$337M	$437M	$434M
Liabilities + Equity	$289M	$430M	$552M	$539M
Shares Outstanding	69,085,980	71,282,000	70,767,000	59,280,000

Nakit Akışı 15

Metrik	2025	2024	2023	2022
D&A	$739.0K	$1M	$1M	$1M
Stock-based Comp	$21M	$67M	$55M	$47M
Deferred Tax	$51.0K	$-63.0K	$-891.0K	$-778.0K
Restructuring	$8M	$0	$0	·
Other Non-cash	$-10M	$-74M	$29M	$26M
Operating Cash Flow	$-125M	$-171M	$-208M	$-164M
CapEx	$0	$221.0K	$583.0K	$3M
Investing Cash Flow	$132M	$177M	$-44M	$-114M
Stock Issued	$5M	$0	$236M	$258M
Stock Repurchased	$10M	$0	$0	·
Net Stock Activity	$-5M	$0	$236M	$258M
Financing Cash Flow	$-4M	$108.0K	$237M	$261M
Net Change in Cash	$2M	$6M	$-15M	$-17M
Taxes Paid	$85.0K	·	·	·
Free Cash Flow	$-125M	$-171M	$-208M	$-166M

Kârlılık 7

Metrik	2025	2024	2023	2022
Operating Margin	·	-283.6%	·	·
Net Margin	·	-246.0%	·	·
Pretax Margin	·	-245.7%	·	·
EBITDA Margin	·	-281.6%	·	·
ROA	-38.1%	-33.8%	-53.6%	-47.7%
ROE	-49.5%	-42.8%	-67.1%	-59.3%
ROIC	-70.9%	-56.8%	-68.3%	-52.3%

Likidite ve Solventlik 2

Metrik	Eğilim	2025	2024	2023	2022
Current Ratio		6.9	7.3	7.2	8.0
Quick Ratio		1.0	0.7	0.4	0.8

Verimlilik 2

Metrik	Eğilim	2025	2024	2023	2022
Asset Turnover		0.0	0.1	·	·
Receivables Turnover		0.0	27.0	·	·

Hisse Başına 5

Metrik	2025	2024	2023	2022
Book Value / Share	$3.13	$4.73	$6.18	$7.32
Revenue / Share	$0.00	$0.95	·	·
Cash Flow / Share	$-1.74	$-2.40	$-3.18	$-3.10
Cash / Share	$0.52	$0.48	$0.40	$0.73
EPS (TTM)	$-1.91	$-2.33	$-4.47	$-4.48

Değerleme (TTM) 10

Metrik	2025	2024	2023	2022
Revenue TTM	$0	$67M	$0	$0
Net Income TTM	$-137M	$-166M	$-292M	$-237M
Market Cap	$93M	$216M	$1.07B	$1.19B
P/E	-0.7	-1.3	-3.4	-4.5
P/S	·	3.2	·	·
P/B	0.4	0.6	2.5	2.8
P / Tangible Book	0.4	0.6	2.5	2.8
P / Cash Flow	-0.7	-1.3	-5.2	-7.3
P / FCF	-0.7	-1.3	-5.1	-7.2
Earnings Yield	-141.5%	-76.9%	-29.5%	-22.2%

Gelir Tablosu 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Revenue	·	·	$0	$0	$0	$0	$27M	$0	$0	$41M	$0	$0	$0	$0
R&D Expense	$35M	$29M	$29M	$23M	$28M	$27M	$33M	$37M	$48M	$50M	$52M	$47M	$43M	$49M
SG&A Expense	$9M	$9M	$8M	$11M	$8M	$11M	$40M	$15M	$17M	$16M	$16M	$16M	$16M	$16M
Operating Expenses	$44M	$38M	$37M	$34M	$36M	$46M	$77M	$51M	$65M	$65M	$68M	$63M	$104M	$65M
Operating Income	$-44M	$-38M	$-37M	$-34M	$-36M	$-46M	$-50M	$-51M	$-65M	$-25M	$-68M	$-63M	$-104M	$-65M
Pretax Income	$-42M	$-35M	$-35M	$-27M	$-27M	$-48M	$-48M	$-40M	$-88M	$10M	$-77M	$-56M	$-99M	$-61M
Income Tax	$138.0K	$120.0K	$442.0K	$0	$0	$0	$-205.0K	$-27.0K	$266.0K	$143.0K	$-135.0K	$31.0K	$-605.0K	$108.0K
Net Income	$-42M	$-35M	$-35M	$-27M	$-27M	$-48M	$-47M	$-40M	$-88M	$10M	$-61M	$-56M	$-113M	$-63M
EPS (Basic)	$-0.59	$-0.50	$-0.50	$-0.37	$-0.37	$-0.67	$-0.67	$-0.56	$-1.24	$0.14	$-0.76	$-0.79	$-1.85	$-1.07
EPS (Diluted)	$-0.59	$-0.50	$-0.50	$-0.37	$-0.37	$-0.67	$-0.67	$-0.56	$-1.24	$0.14	$-0.76	$-0.79	$-1.85	$-1.07
Shares (Basic)	71,326,000	70,264,000	·	72,139,000	71,992,000	71,678,000	·	71,111,000	71,040,000	70,898,000	·	70,612,000	60,790,000	59,277,000
Shares (Diluted)	71,326,000	70,264,000	·	72,139,000	71,992,000	71,678,000	·	71,111,000	71,040,000	71,192,000	·	70,612,000	60,790,000	59,277,000
EBITDA	$-44M	$-38M	·	$-34M	$-36M	$-45M	·	$-51M	$-65M	$-24M	·	$-62M	$-104M	$-65M

Bilanço 23

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Cash & Equivalents	$25M	$32M	$36M	$39M	$38M	$42M	$34M	$41M	$37M	$38M	$28M	$111M	$267M	$36M
Receivables	·	·	$0	$0	$0	$0	$5M	·	·	·	·	·	·	·
Prepaid Expense	$7M	$6M	$7M	$8M	$8M	$10M	$10M	$9M	$13M	$15M	·	$12M	$11M	$18M
Current Assets	$181M	$218M	$253M	$288M	$312M	$343M	$386M	$400M	$440M	$504M	·	$528M	$564M	$410M
PP&E (Net)	$2M	$3M	$3M	$3M	$3M	$3M	$5M	$5M	$5M	$6M	·	$6M	$7M	$7M
PP&E (Gross)	$6M	$6M	$6M	$6M	$6M	$6M	$9M	$9M	$9M	$9M	·	$10M	$9M	$10M
Accum. Depreciation	$3M	$3M	$3M	$3M	$3M	$2M	$4M	$4M	$4M	$3M	·	$3M	$3M	$3M
Goodwill	·	·	·	·	·	·	·	$4M	$4M	$4M	·	$4M	$4M	$4M
Total Assets	$215M	$253M	$289M	$327M	$352M	$384M	$430M	$451M	$492M	$557M	·	$586M	$621M	$489M
Accounts Payable	$8M	$7M	$7M	$7M	$4M	$8M	$7M	$8M	$20M	$11M	·	$14M	$12M	$13M
Accrued Liabilities	$29M	$28M	$29M	$30M	$35M	$42M	$45M	$47M	$46M	$44M	·	$45M	$39M	$44M
Current Liabilities	$38M	$35M	$37M	$37M	$39M	$49M	$53M	$55M	$67M	$55M	·	$59M	$52M	$56M
Capital Leases	$34M	$35M	$36M	$37M	$38M	$39M	$40M	$40M	$41M	$43M	·	$43M	$44M	$45M
Deferred Tax	·	·	·	·	·	·	·	·	·	·	·	$0	$0	$756.0K
Other Non-current Liabilities	$500.0K	$500.0K	$500.0K	$500.0K	$500.0K	$558.0K	$849.0K	$996.0K	$1M	$1M	·	$2M	$2M	$2M
Total Liabilities	$72M	$70M	$73M	$74M	$77M	$89M	$93M	$96M	$109M	$99M	·	$104M	$98M	$104M
Common Stock	$72.0K	$71.0K	$69.0K	$72.0K	$72.0K	$72.0K	$71.0K	$71.0K	$71.0K	$70.0K	·	$70.0K	$70.0K	$59.0K
Paid-in Capital	$1.41B	$1.41B	$1.41B	$1.41B	$1.40B	$1.40B	$1.39B	$1.36B	$1.35B	$1.34B	·	$1.31B	$1.30B	$1.05B
Retained Earnings	$-1.27B	$-1.23B	$-1.19B	$-1.16B	$-1.13B	$-1.10B	$-1.05B	$-1.01B	$-967M	$-878M	·	$-828M	$-772M	$-660M
AOCI	$-78.0K	$-50.0K	$196.0K	$186.0K	$59.0K	$358.0K	$558.0K	$2M	$140.0K	$773.0K	·	$-359.0K	$-338.0K	$-556.0K
Stockholders' Equity	$144M	$183M	$216M	$253M	$274M	$295M	$337M	$354M	$383M	$459M	·	$482M	$523M	$385M
Liabilities + Equity	$215M	$253M	$289M	$327M	$352M	$384M	$430M	$451M	$492M	$557M	·	$586M	$621M	$489M
Shares Outstanding	71,668,568	71,156,113	69,085,980	72,245,529	72,135,453	71,950,683	71,282,400	71,149,666	71,106,719	71,011,982	70,767,000	70,640,684	70,603,663	59,442,342

Nakit Akışı 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
D&A	$152.0K	$151.0K	$157.0K	$160.0K	$160.0K	$262.0K	$317.0K	$321.0K	$327.0K	$324.0K	$337.0K	$348.0K	$344.0K	$360.0K
Stock-based Comp	$3M	$3M	$3M	$5M	$6M	$6M	$31M	$10M	$13M	$13M	$14M	$14M	$13M	$14M
Restructuring	$0	$0	$0	$0	$0	$8M	$0	$0	$0	$0	·	·	·	·
Other Non-cash	·	$-952.0K	·	·	·	$9M	·	·	·	$-75M	·	·	·	$-157.0K
Operating Cash Flow	$-37M	$-33M	$-31M	$-27M	$-35M	$-33M	$-40M	$-44M	$-35M	$-52M	$-41M	$-39M	$-79M	$-49M
CapEx	$0	$34.0K	$0	$0	$0	$0	$0	$0	$181.0K	$40.0K	$173.0K	$91.0K	$319.0K	$0
Investing Cash Flow	$30M	$30M	$32M	$28M	$30M	$40M	$32M	$48M	$34M	$62M	$-42M	$-117M	$73M	$42M
Stock Issued	·	·	·	·	·	·	$0	$0	·	·	$0	$0	·	·
Financing Cash Flow	$65.0K	$-1M	$-5M	$115.0K	$0	$189.0K	$0	$92.0K	$9.0K	$7.0K	$0	$309.0K	$237M	$373.0K
Net Change in Cash	$-7M	$-4M	$-3M	$1M	$-4M	$8M	$-7M	$4M	$-640.0K	$10M	$-83M	$-156M	$230M	$-7M
Free Cash Flow	·	$-33M	·	·	·	$-33M	·	·	·	$-52M	·	·	·	$-49M

Kârlılık 7

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Operating Margin	·	·	·	·	·	·	·	·	·	-61.1%	·	·	·	·
Net Margin	·	·	·	·	·	·	·	·	·	24.8%	·	·	·	·
Pretax Margin	·	·	·	·	·	·	·	·	·	25.1%	·	·	·	·
EBITDA Margin	·	·	·	·	·	·	·	·	·	-60.3%	·	·	·	·
ROA	-14.9%	-11.1%	·	-6.9%	-6.4%	-10.3%	·	-7.8%	-15.9%	1.9%	·	-10.0%	-18.9%	-14.1%
ROE	-20.2%	-14.8%	·	-8.8%	-8.2%	-12.8%	·	-9.6%	-19.5%	2.4%	·	-12.2%	-22.6%	-18.0%
ROIC	-31.0%	-20.8%	·	-13.3%	-13.1%	-15.4%	·	-14.5%	-17.1%	-5.3%	·	-13.0%	-19.7%	-16.9%

Likidite ve Solventlik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Current Ratio		4.8	6.2	·	7.8	8.0	6.9	·	7.3	6.6	9.2	·	9.0	10.9	7.3
Quick Ratio		0.7	0.9	·	1.1	1.0	0.8	·	0.8	0.6	0.7	·	1.9	5.2	0.6

Verimlilik 2

Metrik	Eğilim	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Asset Turnover		·	·	·	0.0	0.0	0.0	·	0.0	0.0	0.1	·	·	·	·
Receivables Turnover		·	·	·	0.0	0.0	0.0	·	·	·	·	·	·	·	·

Hisse Başına 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Book Value / Share	$2.00	$2.57	·	$3.50	$3.81	$4.11	·	$4.98	$5.38	$6.46	·	$6.82	$7.41	$6.49
Revenue / Share	·	·	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.57	·	·	·	·
Cash Flow / Share	·	$-0.47	·	·	·	$-0.46	·	·	·	$-0.73	·	·	·	$-0.83
Cash / Share	$0.35	$0.45	·	$0.54	$0.52	$0.58	·	$0.58	$0.52	$0.53	·	$1.57	$3.78	$0.61
EPS (TTM)	$-1.96	$-1.74	·	$-2.08	$-2.27	$-3.14	·	$-2.42	$-2.65	$-3.26	·	$-4.58	$-4.75	$-4.24

Değerleme (TTM) 9

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Revenue TTM	$0	$0	·	$27M	$27M	$27M	·	$41M	$41M	$41M	·	·	·	·
Net Income TTM	$-140M	$-124M	·	$-149M	$-163M	$-224M	·	$-179M	$-195M	$-219M	·	$-286M	$-285M	$-241M
Market Cap	$348M	$167M	·	$109M	$84M	$114M	·	$262M	$291M	$1.12B	·	$1.42B	$1.99B	$1.02B
P/E	-2.5	-1.3	·	-0.7	-0.5	-0.5	·	-1.5	-1.5	-4.8	·	-4.4	-5.9	-4.1
P/S	·	·	·	4.1	3.1	4.3	·	6.5	7.2	27.6	·	·	·	·
P/B	2.4	0.9	·	0.4	0.3	0.4	·	0.7	0.8	2.4	·	2.9	3.8	2.7
P / Tangible Book	2.4	0.9	·	0.4	0.3	0.4	·	0.7	0.8	2.5	·	3.0	3.8	2.7
P / Cash Flow	·	-5.1	·	·	·	-3.5	·	·	·	-21.5	·	·	·	-20.7
Earnings Yield	-40.4%	-74.4%	·	-137.8%	-195.7%	-197.5%	·	-65.8%	-64.8%	-20.7%	·	-22.8%	-16.8%	-24.6%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$0	$67M	$0	$0	·
Faaliyet Kâr Marjı %	·	-283.6%	·	·	·
Net Gelir	$-137M	$-166M	$-292M	$-237M	$-159M
Seyreltilmiş Hisse Başı Kâr	$-1.91	$-2.33	$-4.47	$-4.48	$-3.72

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	6.9	7.3	7.2	8.0	·
Cari Oran	1.0	0.7	0.4	0.8	·

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$-125M	$-171M	$-208M	$-166M	·

Kurumsal Sahipler (13F) 127 dosya · $225.0M toplam · Tarih itibarıyla 30 Haziran 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 127

Tutulan Değer $225.0M

Yeni pozisyonlar 36

Çıkan pozisyonlar 19

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
36 (+4 önceki Ç'ye göre)	19 (+10 önceki Ç'ye göre)	31 (+1 önceki Ç'ye göre)	33 (+7 önceki Ç'ye göre)	+4.1M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
5AM Venture Management, LLC	$19.147.378	3.947.913	8,51%	Hisse senetleri
BlackRock, Inc.	$18.204.597	3.753.525	8,09%	Hisse senetleri
Squadron Capital Management LLC	$17.945.000	3.700.000	7,98%	Hisse senetleri
TWO SIGMA INVESTMENTS, LP	$14.670.940	3.024.936	6,52%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$13.752.995	2.835.669	6,11%	Hisse senetleri
CITADEL ADVISORS LLC	$11.147.254	2.298.403	4,95%	Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC	$7.804.028	1.609.078	3,47%	Hisse senetleri
Opaleye Management Inc.	$6.851.382	1.412.656	3,05%	Hisse senetleri
ORBIMED ADVISORS LLC	$6.744.294	1.390.576	3,00%	Hisse senetleri
Decheng Capital LLC	$6.418.136	1.323.327	2,85%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$6.229.699	1.284.117	2,77%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$5.406.053	1.114.650	2,40%	Hisse senetleri
Ishara Investments LP	$4.971.250	1.025.000	2,21%	Hisse senetleri
PRIMECAP MANAGEMENT CO/CA/	$4.643.487	957.420	2,06%	Hisse senetleri
Soleus Capital Management, L.P.	$4.607.500	950.000	2,05%	Hisse senetleri
STATE STREET CORP	$4.303.968	887.416	1,91%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$3.921.458	808.548	1,74%	Hisse senetleri
VANGUARD GROUP INC	$3.855.047	2.855.590	1,71%	Hisse senetleri
Pfizer Inc	$3.853.489	953.834	1,71%	Hisse senetleri
Connor, Clark & Lunn Investment Management Ltd.	$3.676.460	758.033	1,63%	Hisse senetleri
MILLENNIUM MANAGEMENT LLC	$3.221.763	664.281	1,43%	Hisse senetleri
ADAR1 Capital Management, LLC	$3.165.838	652.750	1,41%	Hisse senetleri
MARSHALL WACE, LLP	$2.868.644	591.473	1,28%	Hisse senetleri
Qube Research & Technologies Ltd	$2.787.809	574.806	1,24%	Hisse senetleri
D. E. Shaw & Co., Inc.	$2.650.845	546.566	1,18%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$2.630.116	542.852	1,17%	Hisse senetleri
MORGAN STANLEY	$2.285.563	471.250	1,02%	Hisse senetleri
Squadron Capital Management LLC	$2.066.100	426.000	0,92%	Alım opsiyonu
TWO SIGMA ADVISERS, LP	$2.002.725	1.483.500	0,89%	Hisse senetleri
NORTHERN TRUST CORP	$1.883.251	388.299	0,84%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$1.806.936	372.564	0,80%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$1.634.159	336.940	0,73%	Hisse senetleri
FMR LLC	$1.504.780	310.264	0,67%	Hisse senetleri
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	$1.451.844	961.486	0,65%	Hisse senetleri
Seven Fleet Capital Management LP	$1.451.432	317.600	0,65%	Hisse senetleri
UBS Group AG	$1.442.283	297.378	0,64%	Hisse senetleri
XTX Topco Ltd	$1.405.011	289.693	0,62%	Hisse senetleri
Creative Planning	$1.382.250	285.000	0,61%	Hisse senetleri
SEI INVESTMENTS CO	$1.241.983	256.079	0,55%	Hisse senetleri
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$1.043.298	215.113	0,46%	Hisse senetleri
Peapod Lane Capital LLC	$983.890	202.864	0,44%	Hisse senetleri
CDC Financial, Inc.	$862.146	177.762	0,38%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$833.768	171.911	0,37%	Hisse senetleri
Invesco Ltd.	$784.037	161.657	0,35%	Hisse senetleri
Stonepine Capital Management, LLC	$783.678	161.583	0,35%	Hisse senetleri
BARCLAYS PLC	$770.452	158.856	0,34%	Hisse senetleri
Anfield Capital Management, LLC	$642.367	274.516	0,29%	Hisse senetleri
Informed Momentum Co LLC	$615.286	126.863	0,27%	Hisse senetleri
Quarry LP	$606.803	125.114	0,27%	Hisse senetleri
Bank of New York Mellon Corp	$592.030	122.068	0,26%	Hisse senetleri

Tüm 127 kurumsal sahibi göster →

Aktivistler ve %5+ sahipler 2 pozisyon

18

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi	Dosyalandı	Hisse	Durum	Amaç	Başvuru
Matrix Capital Management Company, LP, David E. Goel ×2 başvurular	02 Ocak 2026	0,00%	Değişiklik	·	SEC
Matrix Capital Management Company LP, David E. Goel ×2 başvurular	20 Haziran 2023	·	İlk başvuru	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Şirket yöneticileri 23 içeriden öğrenenler · 16 yöneticiler · 10 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Julia Marie Eastland	CEO & President	09 Şubat 2026 S	79.133	2	$-21.239
Kimberly Blackwell	Chief Executive Officer	01 Şubat 2024 A	484.145	0	$0
Anthony Y Sun	President & CEO	05 Nisan 2022 S	1.175.589	0	$0
Cam Gallagher	President, Interim CFO	31 Mayıs 2024 S	633.680	0	$0
Melissa B, Epperly	Chief Financial Officer	12 Şubat 2024 S	451.449	0	$0
Iris Roth	Chief Operating Officer	01 Mart 2023 A	52.500	0	$0
Ingmar Bruns	Chief Medical Officer	30 Eylül 2026 A	43.059	2	$-7.999
Vincent Vultaggio	PAO and PFO	10 Şubat 2026 S	146.506	5	$-105.418
James B Bucher	Chief Legal Officer	08 Ocak 2026 A	·	0	$0
Andrea Paul	Chief Legal Officer	03 Şubat 2025 A	1.070.784	0	$0
Mark Lackner	Chief Scientific Officer	03 Şubat 2025 A	512.856	0	$0
Diana Hausman	Chief Medical Officer	09 Mayıs 2024 S	373.876	0	$0
Kevin D. Bunker	Chief Scientific Officer	20 Aralık 2023 G	834.931	0	$0
Carrie Brownstein	Chief Medical Officer	04 Ekim 2023 S	105.685	0	$0
Alexis Pinto	Chief Legal Officer	10 Şubat 2022 A	22.240	0	$0
Dimitris Voliotis	SVP, Clinical Development	10 Şubat 2022 A	15.978	0	$0
Enoch Kariuki	Yönetim kurulu üyesi	16 Haziran 2026 A	194.465	0	$0
Jan Skvarka	Yönetim kurulu üyesi	16 Haziran 2026 A	264.254	0	$0
David Michael Johnson	Yönetim kurulu üyesi	16 Haziran 2026 A	307.521	0	$0
Luke Nathaniel Walker	Yönetim kurulu üyesi	16 Haziran 2026 A	201.384	0	$0
Scott Dunseth Myers	Yönetim kurulu üyesi	16 Haziran 2026 A	395.895	0	$0
Shannon Campbell	Yönetim kurulu üyesi	26 Mayıs 2026 A	114.200	0	$0
Recurium Equity, LLC	10% sahip	28 Ekim 2020 J	14.990	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 18 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
IWC · iShares Trust	0,04%	170.201 SH	11 Eylül 2026	Günlük
OMFS · Invesco Exchange-Traded Self-Indexe…	0,02%	21.344 SH	01 Ekim 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,02%	43.495 SH	19 Ağustos 2026	Günlük
PRFZ · Invesco Exchange-Traded Fund Trust	0,01%	113.841 SH	01 Ekim 2026	Günlük
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	289.218 SH	19 Ağustos 2026	Günlük
RSSL · Global X Funds	0,01%	23.883 NS	31 Temmuz 2026	N-PORT
IWM · iShares Trust	0,01%	1.282.558 SH	11 Eylül 2026	Günlük
DFAS · Dimensional ETF Trust	0,00%	154.468 NS	31 Temmuz 2026	N-PORT
DXUV · Dimensional ETF Trust	0,00%	4.890 NS	31 Temmuz 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	10.234 NS	31 Temmuz 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	10.252 NS	31 Temmuz 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	8.219 NS	31 Temmuz 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	9.284 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	575.846 SH	19 Ağustos 2026	Günlük
VTI · VANGUARD INDEX FUNDS	0,00%	2.187.299 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	4.227 SH	19 Ağustos 2026	Günlük
VHT · VANGUARD WORLD FUND	0,00%	151.148 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	483.199 SH	11 Eylül 2026	Günlük

ZNTL Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 16 analist AL

Medyan hedef $6.00 +138,1%

4 25,0% Güçlü Al

6 37,5% Al

6 37,5% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

9 analist · 2026-09-29

Ortalama hedef $6.89 +173,4%

← Tüm hedeflerin altında Mevcut fiyat $2.52

Düşük$4.00 Ortalama$6.89 Yüksek$10.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
ZNTL	$93M	-0.7	·	·	-49.5%	·
ARCT	$174M	-2.6	-46.1%	-80.2%	-29.6%	·
INDP	$6M	-0.1	·	·	-2820.8%	·
CCCC	$185M	-1.5	1.0%	-292.1%	-48.8%	·
FENC	$263M	-22.6	-6.1%	-21.8%	-69.6%	·
OCGN	$422M	-5.6	8.8%	-1537.4%	1488.8%	·
SRZN	·	·	·	·	·	·
CABA	$220M	-1.0	·	·	-115.5%	·
ARTV	·	-1.3	-99.2%	·	·	·
CYPH	$97M	16.6	·	·	6.1%	·
EBS	$644M	13.3	-28.8%	7.1%	9.9%	·

Son Haberler Bu şirketten bahseden son manşetler

23

Zentalis (ZNTL) Kanser İlacı Dozunu Sabitledi; Jefferies Hedefi Yükseltti Yahoo Finance · 5 ay, 1 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

ZNTL Zentalis Pharmaceuticals, Inc. - common stock